chronic hepatitis c
Item
documented chronic hepatitis c (chc) genotype 1 infection
boolean
C0524910 (UMLS CUI [1])
therapy naive; therapy ribavirin
Item
treatment naïve or failed previous interferon/ribavirin therapy (≥12 uninterrupted weeks)
boolean
C0919936 (UMLS CUI [1])
C0087111 (UMLS CUI [2,1])
C0035525 (UMLS CUI [2,2])
weight; screening
Item
weigh between 10 kg to 90 kg inclusive at screening and baseline (day -1).
boolean
C0005910 (UMLS CUI [1])
C0220908 (UMLS CUI [2])
body mass index; center for disease control and prevention
Item
body mass index (bmi) from the 5th to the 95th percentile for the participant's age and gender, inclusive, per tables from the center for disease control and prevention, usa
boolean
C1305855 (UMLS CUI [1])
C0007670 (UMLS CUI [2])
contraception
Item
use of acceptable methods of contraception for at least 3 months prior to baseline and continue on study
boolean
C0700589 (UMLS CUI [1])
HBV coinfection; human immunodeficiency virus infection
Item
co-infection with the human immunodeficiency virus (hiv) or hepatitis b virus (hbsag positive).
boolean
C2242656 (UMLS CUI [1])
C0019693 (UMLS CUI [2])
therapy interferon-alfa
Item
treatment with ribavirin within 90 days, or any interferon-alfa within 30 days
boolean
C0087111 (UMLS CUI [1,1])
C0002199 (UMLS CUI [1,2])
adverse events therapy interferon-alfa
Item
discontinued from interferon treatment due to adverse events
boolean
C0877248 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0002199 (UMLS CUI [1,3])
Antiviral Therapy
Item
currently receiving antiviral/immunomodulating therapy for hepatitis c
boolean
C0280274 (UMLS CUI [1])
therapy hcv protease inhibitor
Item
prior treatment with an hcv protease inhibitor
boolean
C0087111 (UMLS CUI [1,1])
C3160091 (UMLS CUI [1,2])
drugs hepatotoxic; Herbal Drugs
Item
prior treatment with any known hepatotoxic agent (including herbal remedies)
boolean
C0013227 (UMLS CUI [1,1])
C0235378 (UMLS CUI [1,2])
C1360419 (UMLS CUI [2])
study drug
Item
use of investigational drugs within 30 days of enrollment into study
boolean
C0013227 (UMLS CUI [1,1])
C0008972 (UMLS CUI [1,2])
liver disease decompensated; ascites; hepatic encephalopathy
Item
evidence of de-compensated liver disease including, but not limited to, a history or presence of clinical ascites, bleeding varices, or hepatic encephalopathy.
boolean
C0023895 (UMLS CUI [1,1])
C0205434 (UMLS CUI [1,2])
C0003962 (UMLS CUI [2])
C0019151 (UMLS CUI [3])
Substance Use Disorder
Item
substance abuse (including but not limited to alcohol abuse, illicit drugs,
boolean
C0038586 (UMLS CUI [1])
Inhalation of Drugs; Marijuana Abuse
Item
inhalational drugs, marijuana use, etc) any time prior to entry into the study
boolean
C0086464 (UMLS CUI [1])
C0024809 (UMLS CUI [2])
concomitant therapy; drug elimination; drug metabolism
Item
any surgical or medical condition which might significantly alter the absorption, distribution, metabolism or excretion of any drug.
boolean
C1707479 (UMLS CUI [1])
C0683141 (UMLS CUI [2])
C0683140 (UMLS CUI [3])
pregnancy; lactating
Item
pregnant or breastfeeding female
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
exclusion criteria
Item
meeting any of the laboratory exclusion criteria
boolean
C0680251 (UMLS CUI [1])